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TECHNICAL NOTE
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The study of the renal handling of uric acid by
micropuncture techniques has been severely ham-
pered by the lack of a reliable microanalytic method
for determining the urate concentration in nanoliter
quantities of tubular fluid. The problem is further
compounded in studies in the rat, in which the
plasma concentrations of urate are low. Differing
nonspecific (nonuricase) chemical micromethods
adaptable to micropuncture studies have been re-
ported by Greger, Lang, and Deetjen and by Roch-
Rainel et al [1, 2]. The results of these studies, how-
ever, have yielded results that are not concordant.
Moreover, in urine samples, Roch-Ramel et al have
suggested that the methodology used by Greger et
al may have been significantly influenced by the
presence of nonurate-reducing substances [2]. Oth-
er than this comparison, no studies have been per-
formed by other laboratories, for either of the re-
ported chemical micromethods, to confirm or refute
the findings of these two investigative groups. Re-
cently, Kissinger and Pachla reported the use of
high-performance liquid chromatography with elec-
trochemical detection (HPLC) for determining
urate concentrations in fluid samples [3]. In a pre-
liminary report, Roch-Ramel and Peters have pre-
sented evidence that HPLC could be adapted to na-
noliter sample sizes [4]. The current report details
the use of HPLC as adapted to sample sizes of sev-
eral nanoliters and the use of this system in micro-
perfusion studies in the rat.
The HPLC apparatus (Bioanalytical Systems,
Inc., W. Lafayette, Indiana) consists of a column,
an amperometric detector (LC-3) with built-in elec-
trical shield, and a carbon paste electrode. The col-
umns evaluated and the operational characteristics
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are summarized in Table 1. Standards and test sam-
ples were diluted with the mobile phase buffer. An
aliquot was then applied to the column, eluted, and
passed through the electrochemical detector. Urate
appeared as a single narrow peak such that the
height of the displacement recorded on the graph
could be correlated with the amount of urate in the
sample. The urate peak could be completely abol-
ished by before incubating the sample in excess
amounts of uricase (Sigma Chemical Co., St. Louis,
Missouri) dissolved in 0.1 M sodium phosphate at a
pH of 8.5 and a temperature of 25° C for 5 mm. Fig-
ure 1 is the results of a typical calibration run ob-
tamed with the anion exchange column. The stan-
dard curve is linear over a range of 25 to 500 pg/
sample. Comparable results were obtained with the
reverse-phase column. Recoveries of known quan-
tities of urate averaged 99.6% (N = 3). The varia-
tions in running single samples from the same urate
standards, including pipetting errors, was
It was found in preliminary studies that urate con-
tamination of glassware was a potential source of
error. Accordingly, all glassware were presoaked in
0.1 M ammonium hydroxide. Prior to use, they were
rinsed with glass-distilled water.
The microinjection syringe was cleaned prior to
each sample by successive washings (50p1/wash) as
follows: (1) two with glass-distilled water; (2) one
with uricase in phosphate buffer (the uricase solu-
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Stationary phase
Column length and internal
diameter
Mobile phase buffer
Flow rate, mi/mm
Retention time, mm
Applied potential of
electrochemical
detector, volts
Injection valve
Sample processing
Vydac SAX
50 cm x 2 mm
Sodium acetate
(0.1 M; pH, 5.35)
Rheodyne type 50c
5.4-ni sample diluted
to 50 p1 with mobile-
phase acetate buffer.
25-111 aliquot applied
to column.
tion remained in the syringe for 2 to 3 mm); (3) four
with glass-distilled water; (4) two with 0.1 M ammo-
nium hydroxide; (5) two with 0.1 M nitric acid; (6)
ten with glass-distilled water; and (7) two with the
sodium acetate buffer. With these washing proce-
dures, urate contamination could be eliminated.
Micropuncture studies. Male Sprague-Dawley
rats were anesthetized and prepared for micro-
puncture as previously described [5]. Intratubular
microperfusion studies in the proximal convoluted
tubule were performed between oil blocks with an
equilibrium microperfusion solution containing so-
dium chloride (110 mEq/liter) and mannitol, adjust-
ed to a final osmolality of 280 mOsm/kg H20 and a
pH of 7.4. 2-'4C-Urate (57 Ci/mmo1, 335 p.Cilmg)
Customsphere S,.s ODS"
150 mm x 4.6 mm
Sodium acetate
(0.1 M; pH, 5.35)
Valco no. CV6UHPaN60d
5.4-nI sample diluted
to 10 p.l with mobile-
phase acetate buffer.
6-111 aliquot applied
to column.
10
Customsphere 5 e ODS'
150 mm x 4.6mm
Ammonium phosphate
(0.05 M; pH, 4.5)
Valco no. CV-6-UHPa-N60"
5.4-ni sample diluted
to 10 p1 with mobile-
phase phosphate buffer.
6-il aliquot applied
to column.
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Fig. 2. Relationship between the Concentration of urate in the
collected perfusate calculated from the isotope counts and di-
rectly determined by high-performance liquid chromatography.
Each point represents an individual collection from the absorp-
tive studies (open circles) or the secretory studies (closed cir-
cles). The line of identity is shown.
(Amersham Searle, Arlington Heights, Illinois) in
varying concentrations from 1 to 13 mgldl, was add-
ed to the microperfusion solution. Urate concentra-
tions in the collected perfusate were calculated
from the known specific activity of the original per-
fusion solution and the change in isotope counts in
Table!. Operational characteristics of high-performance liquid chromatography with electrochemical detection for the
determination of urate concentrations
Anion exchange Reverse phase
0.35 0.35
4.5 4.5
+0.8 +0.8
1.3
2
+0.8
a Separations Group, Hesperian, California (SAX is strong anion exchange)
"Ce! Associates, Houston, Texas (ODS is decyl silyl)
Rheodyne, Inc., Berkeley, California
Valco Instrument Co., Houston, Texas
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Fig. 1. Calibration curve for urate standards in picograms per
sample as a function of displacement determined by high-per-
formance liquid chromatography with electrochemical detec-
tion. In the example shown, the sample size is 5.4 nI.
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the collected perfusate. In the same samples, urate
concentrations were determined chemically by
HPLC. The ratio of urate concentration determined
chemically to that calculated from isotopic mea-
surements was 1.03 0.07 0.02 (mean SD
sEM). In separate studies, peritubular capillaries
were perfused simultaneously with the tubular mi-
croperfusions. In these studies, varying concentra-
tions of 2-'4C-urate from 5 to 20 mg!dl were added to
the capillary perfusate. No urate was added to the
equilibrium solution perfusing the lumen. The urate
concentration in the collected luminal perfusate was
analyzed for isotope counts and chemical urate con-
centration. The urate concentration in the luminal
perfusate was calculated from the specific activity
of the capillary perfusion solution and under the as-
sumption that urate in the cell had equilibrated with
the isotope. In 21 samples, the ratio of measured to
calculated urate concentrations was 1.02 0.15
0.04. Figure 2 summarizes the individual data points
from both the absorptive and secretory studies.
As noted in the introduction and as discussed pre-
viously, the determination of urate concentration in
ultramicrosamples has been difficult [6]. In other
studies, especially microperfusion studies, reported
from this laboratory, the rate of loss of 2-'4C-urate
from the lumen has been used as a marker for the
absorptive flux [5, 7]. These results have generally
been expressed as the percent absorption per milli-
meter of tubule, because it had not been determined
that the specific activity remained constant along
the length of the nephron. The lack of evidence for
the constancy of specific activity has made it impos-
sible to express the flux of urate, in absolute terms,
with any certainty.
The present report, along with that of Roch-Ra-
mel and Peters, indicates the feasibility of using
HPLC with electrochemical detection for determin-
ing urate concentration in microsamples, such as
can be obtained in micropuncture or microperfusion
studies [4]. The system is sensitive to at least 25 pg/
sample, and the standard curves are linear over a
wide range. Reproducibility and recoveries are ex-
cellent and, at least in microperfusion studies, are
not influenced by other constituents possibly enter-
ing the microperfusion solutions. Due to the sensi-
tivity of the technique, urate contamination of
glassware remains a potential source of error. The
washing procedures described appear to have been
effective in eliminating this problem.
The results reported in this communication in-
dicate excellent agreement between the calculated
values for urate concentrations determined from
isotope counting and that determined chemically by
HPLC. These findings suggest that, under appropri-
ate experimental conditions, the isotope flux accu-
rately predicts the chemical flux of urate, and the
exchange of unlabeled for labeled urate is not a sig-
nificant variable. The use of HPLC therefore ap-
pears to be a most promising new microanalytical
tool with which to elucidate the mechanisms sub-
serving the tubular absorption and secretion of
urate.
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